Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 4
2006 3
2007 3
2008 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Src continues aging: current and future clinical directions.
Kopetz S, Shah AN, Gallick GE. Kopetz S, et al. Clin Cancer Res. 2007 Dec 15;13(24):7232-6. doi: 10.1158/1078-0432.CCR-07-1902. Clin Cancer Res. 2007. PMID: 18094400 Free article. Review.
Src, chemoresistance and epithelial to mesenchymal transition: are they related?
Shah AN, Gallick GE. Shah AN, et al. Anticancer Drugs. 2007 Apr;18(4):371-5. doi: 10.1097/CAD.0b013e32801265d7. Anticancer Drugs. 2007. PMID: 17351389 Review.
Gemcitabine resistance in pancreatic cancer: picking the key players.
Kim MP, Gallick GE. Kim MP, et al. Clin Cancer Res. 2008 Mar 1;14(5):1284-5. doi: 10.1158/1078-0432.CCR-07-2247. Clin Cancer Res. 2008. PMID: 18316544 Free article. No abstract available.
Development and characterization of gemcitabine-resistant pancreatic tumor cells.
Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, Gallick GE. Shah AN, et al. Ann Surg Oncol. 2007 Dec;14(12):3629-37. doi: 10.1245/s10434-007-9583-5. Epub 2007 Oct 2. Ann Surg Oncol. 2007. PMID: 17909916
Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Andtbacka RH, Dunner K Jr, Pal A, Bornmann WG, Chiao PJ, Huang P, Xiong H, Abbruzzese JL, McConkey DJ. Nawrocki ST, et al. Cancer Res. 2006 Apr 1;66(7):3773-81. doi: 10.1158/0008-5472.CAN-05-2961. Cancer Res. 2006. PMID: 16585204 Free article.
The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts.
Nawrocki ST, Sweeney-Gotsch B, Takamori R, McConkey DJ. Nawrocki ST, et al. Mol Cancer Ther. 2004 Jan;3(1):59-70. Mol Cancer Ther. 2004. PMID: 14749476 Free article.
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases.
Lesslie DP, Summy JM, Parikh NU, Fan F, Trevino JG, Sawyer TK, Metcalf CA, Shakespeare WC, Hicklin DJ, Ellis LM, Gallick GE. Lesslie DP, et al. Br J Cancer. 2006 Jun 5;94(11):1710-7. doi: 10.1038/sj.bjc.6603143. Br J Cancer. 2006. PMID: 16685275 Free PMC article.
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Trevino JG, Summy JM, Lesslie DP, Parikh NU, Hong DS, Lee FY, Donato NJ, Abbruzzese JL, Baker CH, Gallick GE. Trevino JG, et al. Am J Pathol. 2006 Mar;168(3):962-72. doi: 10.2353/ajpath.2006.050570. Am J Pathol. 2006. PMID: 16507911 Free PMC article.
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.
Nawrocki ST, Carew JS, Dunner K Jr, Boise LH, Chiao PJ, Huang P, Abbruzzese JL, McConkey DJ. Nawrocki ST, et al. Cancer Res. 2005 Dec 15;65(24):11510-9. doi: 10.1158/0008-5472.CAN-05-2394. Cancer Res. 2005. PMID: 16357160 Free article.
The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model.
Minard ME, Herynk MH, Collard JG, Gallick GE. Minard ME, et al. Oncogene. 2005 Apr 7;24(15):2568-73. doi: 10.1038/sj.onc.1208503. Oncogene. 2005. PMID: 15735692 Free article.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page